本文關(guān)鍵詞： 臍帶間充質(zhì)干細(xì)胞 放射性肺纖維化 細(xì)胞治療　出處：《第三軍醫(yī)大學(xué)學(xué)報(bào)》2017年10期 　論文類型：期刊論文

【摘要】：目的觀察臨床級(jí)臍帶間充質(zhì)干細(xì)胞(clinical grade umbilical cord mesenchymal stem cell,UC-MSC)治療放射性肺纖維化(radiation-induced pulmonary fibrosis,RPF)的安全性和有效性。方法從2014年1月至2016年6月共入組8例RPF患者,其中2例乳腺癌,6例肺癌。通過支氣管鏡對(duì)RPF病灶部位灌洗后單次注入臍帶間充質(zhì)干細(xì)胞(1×10~6/kg),觀察治療前及治療后第3天、3個(gè)月、6個(gè)月的臨床癥狀、血液指標(biāo)和圣喬治呼吸問卷(St George’s respiratory questionnaire,SGRQ)、6 min步行距離(six-minute walk distance,6MWD)、肺功能指標(biāo)、相關(guān)炎癥因子、CT肺密度的變化情況。結(jié)果 8例患者均能耐受UC-MSC治療,6例患者自覺氣促、咳嗽等癥狀有所好轉(zhuǎn),圣喬治呼吸問卷評(píng)分有差異(P0.05),血常規(guī)、C反應(yīng)蛋白、肝腎功指標(biāo)治療前后無明顯變化,轉(zhuǎn)化生長因子-β1(transforming growth factor-β1,TGF-β1)在治療后有下降趨勢,但差異無統(tǒng)計(jì)學(xué)意義(P0.05),CT肺密度自身治療前后比較有下降。結(jié)論 UC-MSC治療RPF對(duì)患者的肝腎等主要臟器無損害,且能夠減輕患者的臨床癥狀和降低肺纖維化密度,但其確切的治療效果及機(jī)制需更加嚴(yán)謹(jǐn)?shù)难芯窟M(jìn)一步證實(shí)。
[Abstract]:Objective to observe clinical grade umbilical cord mesenchymal stem cell of umbilical cord mesenchymal stem cells. UC-MSCI was used to treat radiation-induced pulmonary fibrosis. Methods from January 2014 to June 2016, 8 patients with RPF were enrolled, 2 of them were breast cancer. Six cases of lung cancer were treated with bronchoscopy. Umbilical cord mesenchymal stem cells were injected with 1 脳 10 ~ (-6) / kg ~ (-1) 路kg ~ (-1) of umbilical cord mesenchymal stem cells by bronchoscopy. Before treatment and 3 days after treatment, 3 months after treatment were observed. Six months of clinical symptoms, blood indicators and St George's respiratory questionnaire questionnaire (St George's respiratory questionnaire SGRQ). 6 min walking distance from six-minute walk distension to 6MW DX, pulmonary function index, and related inflammatory factors. Results the changes of lung density in CT were all able to tolerate UC-MSC treatment in 6 patients with spontaneous shortness of breath and cough. The score of St. George's Respiratory questionnaire was significantly different (P 0.05). There was no significant change in serum C-reactive protein and liver and kidney function before and after treatment. Transforming growth factor- 尾 _ 1 was transformed into growth factor- 尾 _ 1. TGF- 尾 1) decreased after treatment, but the difference was not statistically significant (P 0.05). Conclusion UC-MSC can not damage the main organs such as liver and kidney, and can alleviate the clinical symptoms and reduce the density of pulmonary fibrosis. But its exact therapeutic effect and mechanism need to be further confirmed by more rigorous research.
【作者單位】： 第三軍醫(yī)大學(xué)西南醫(yī)院呼吸內(nèi)科;第三軍醫(yī)大學(xué)西南醫(yī)院老年科;
【基金】：中國科學(xué)院戰(zhàn)略性先導(dǎo)專項(xiàng)項(xiàng)目(XDA 01030000)~~
【分類號(hào)】：R730.55
【正文快照】： 放射性肺損傷是在對(duì)胸部惡性腫瘤(肺癌、乳腺南醫(yī)院和新橋醫(yī)院放療中心篩選放療病人1 829例,癌、食管癌等)進(jìn)行放射治療時(shí)引起的肺組織損傷。根據(jù)納入標(biāo)準(zhǔn)共入組8例RPF患者,患者具體篩選流根據(jù)放射性肺損傷發(fā)生在放療后的時(shí)間不同分為:放程圖見圖1,其中2例乳腺癌,6例肺癌,年齡

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 李艷菊;劉洋;王茜;;間充質(zhì)干細(xì)胞治療[J];中國輸血雜志;2008年10期

2 廖聯(lián)明,韓欽,趙春華;間充質(zhì)干細(xì)胞在免疫治療中的應(yīng)用[J];中國實(shí)驗(yàn)血液學(xué)雜志;2005年01期

3 殷江紅;;臍帶間充質(zhì)干細(xì)胞治療1型糖尿病1例護(hù)理[J];實(shí)用醫(yī)藥雜志;2013年01期

4 戈霞暉;白沖;;間充質(zhì)干細(xì)胞發(fā)揮治療作用的機(jī)制研究[J];廣東醫(yī)學(xué);2010年20期

5 楊華強(qiáng);李紅;胡明均;李玉玲;鮑紅霞;呂曉娟;;臍帶間充質(zhì)干細(xì)胞治療糖皮質(zhì)激素耐藥的慢性移植物抗宿主病五例[J];中華臨床醫(yī)師雜志(電子版);2013年12期

6 劉岐煥;程范軍;陳龍;唐俊明;王家寧;高清平;;粒細(xì)胞集落刺激因子對(duì)小鼠骨髓間充質(zhì)干細(xì)胞的作用[J];武漢大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2007年03期

7 王文文;濮益琴;;5例異基因造血干細(xì)胞移植術(shù)后合并癥應(yīng)用人臍帶間充質(zhì)干細(xì)胞患者的護(hù)理[J];內(nèi)蒙古中醫(yī)藥;2013年04期

8 田z，

本文編號(hào)：1464683